Miller Edward's Form 4 filing
Kalaris Therapeutics, Inc. (KLRS) · filed Oct 23, 2024
- Accession no.
- 0000950170-24-116644
- Filed
- Oct 23, 2024
- Trade date
- Oct 21-22, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.09K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Miller EdwardCIK 0001619252 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | Common Stock | SSaleDisposed | −635 | $0.78 | −$495.3 | 214,969 | Direct | |
| Oct 22, 2024 | Common Stock | SSaleDisposed | −766 | $0.77 | −$589.82 | 214,203 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.